Home pageBBN • SWX
add
Bellevue Group AG
Chiusura precedente
14,10 CHF
Intervallo giornaliero
13,50 CHF - 14,15 CHF
Intervallo annuale
11,05 CHF - 24,30 CHF
Cap di mercato
181,73 Mln CHF
Volume medio
9331,00
Rapporto P/E
12,18
Dividendo/Prezzo
8,52%
Borsa valori principale
SWX
Notizie del mercato finanziario
Dati finanziari
Conto economico
Entrate
Utile netto
(CHF) | giu 2024info | Variazione Y/Y |
---|---|---|
Entrate | 18,41 Mln | -11,31% |
Spese di gestione | 13,73 Mln | -10,56% |
Utile netto | 3,72 Mln | -7,22% |
Margine di profitto netto | 20,18 | 4,61% |
Utili per azione | — | — |
EBITDA | — | — |
Aliquota fiscale effettiva | 17,26% | — |
Stato patrimoniale
Totale attivo
Totale passivo
(CHF) | giu 2024info | Variazione Y/Y |
---|---|---|
Investimenti cash/breve termine | 30,49 Mln | 100,63% |
Totale attivo | 138,75 Mln | -4,69% |
Totale passivo | 22,05 Mln | -24,81% |
Patrimonio netto totale | 116,70 Mln | — |
Azioni in circolazione | 13,20 Mln | — |
Prezzo/valore contabile | 1,60 | — |
Redditività dell'attivo | 10,71% | — |
Rendimento sul capitale | — | — |
Flusso di cassa
Flusso di cassa netto
(CHF) | giu 2024info | Variazione Y/Y |
---|---|---|
Utile netto | 3,72 Mln | -7,22% |
Liquidità di esercizio | 3,65 Mln | 137,31% |
Contanti da investimenti | — | — |
Contanti da finanziamenti | -8,10 Mln | 45,85% |
Flusso di cassa netto | -4,17 Mln | 83,13% |
Flusso di cassa libero | — | — |
Informazioni
Bellevue Group AG, headquartered in Zurich, is a listed investment management corporation from Switzerland. Bellevue Group consists of the subsidiaries Bellevue Asset Management, Bellevue Private Markets and StarCapital. It has 9,6 billion Swiss francs Assets Under Management Around 80% of clients assets are in healthcare investments. Bellevue Group is also active in alternative investments and private equity, including co-investments in private domestic small and medium-sized enterprises. In this business area, client assets under management were 1.0 billion francs as of mid-2021.
Bellevue Group is among the largest investors in the health care segment worldwide. It has subsidiaries in Germany, UK and USA, and is focusing on platform companies with products in phase two trials or later who preferably develop technologies that can be applied in multiple ways. One of the Bellevue Asset Management teams manages the BB Biotech investment company. The former investment company BB Medtech, which was converted into an equity fund at the end of September 2009, is also managed by Bellevue Asset Management. Wikipedia
CEO
Fondazione
1993
Sito web
Dipendenti
88